Selected Reads

Smartkarma

Equity Bottom-Up

We previously wrote up PDLI in 2019, which was a cash-rich pharma royalty company Sum-Of-The-Parts story. Its value was ultimately unlocked for a solid return. We think this situation rhymes...<a target="_blank" href="https://www.valueinvestorsclub.com/idea/Vanda_Pharmaceuticals_Inc./3031216837">Read the article on Value Investor Club »</a>

United States

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00